Author Profile

Jeng LB

Clinical researcher bridging the gap between preclinical nanoparticle development and translational oncology.

1
Publications
1
Specialties
1
Years Active
● Publications

Research by Jeng LB

ACS nano • 2026

Can New P-Selectin Targeting Nanoparticles Double Survival in Triple-Negative Breast Cancer?

Treating triple-negative breast cancer (TNBC) is notoriously difficult because tumors create a protective microenvironment that blocks stand...

Read summary →